Las Vegas, NV -- (SBWIRE) -- 09/21/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.EquityObserver.com issues a special report on the following stocks: Avanir Pharmaceuticals Inc(NASDAQ:AVNR), Exelixis Inc.(NASDAQ:EXEL), Covidien plc (NYSE:COV), Allscripts Healthcare Solutions Inc(NASDAQ:MDRX)
Avanir Pharmaceuticals Inc(NASDAQ:AVNR) managed to keep its gain at 0.46% on above-normal volume of 7.34 million shares. The stock settled at $4.35 after floating in a range of $2.07 to $4.44. Its latest price was $4.35, reaching market capitalization of $632.79 million. Its 52-week range has been $2.07 to $6.00. Avanir Pharmaceuticals, Inc., together with its subsidiaries, engages in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States.
What was the Moving Force behind AVNR On Bullish Run? Read This Research Report on AVNR
Exelixis, Inc.(NASDAQ:EXEL) saw its price gain on above-normal volume, as 6.14 million shares changed hands when compared with its average daily volume of 1.41 million shares. The stock was up 1.25% to $5.68. It has gained over the last 12 months, increasing 2.25% and marked new low $4.29. Exelixis, Inc., a biotechnology company, engages in developing small molecule therapies for the treatment of cancer in the United States. It focuses on developing and commercializing COMETRIQ (cabozantinib).
Why Should Investors Buy EXEL After The Recent Gain? Just Go Here and Find Out
Covidien plc (NYSE:COV) settled -0.22% lower at $63.05 on above-normal volume of 5.52 million shares during the last trading day. The stock has its 12-month high at $68.83 and 52-week low price was $53.36. It traded in a range of $62.69 to $63.54 during the last trading day. Covidien plc develops, manufactures, and sells healthcare products for use in clinical and home settings worldwide.
Why Should Investors Buy COV After the Recent Fall ? Just Go Here and Find Out
Allscripts Healthcare Solutions Inc(NASDAQ:MDRX) traded up on a volume of 5.23 million, higher than its standard daily volume. Shares have gained 0.73% to $15.12. Over the last twelve months, the stock has added 40.39% and faced a best price of $16.43. Allscripts Healthcare Solutions, Inc. provides clinical, financial, connectivity, and information solutions and related professional services to hospitals, physicians, and post-acute organizations primarily in the United States and Canada.
For How Long MDRX will Fight for Profitability? Read This Trend Analysis report
About Equity Observer
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/ employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/disclaimer-2/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)